Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation
- 30 August 2022
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 454, 116214
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangdong Province (2019A1515010583, 2022A1515012560)
- Guangzhou Municipal Science and Technology Program key projects (202201011723)
- National Key Research and Development Program of China (2020YFC1200100, 2021YFC2300800, 2021YFC2300801)
This publication has 47 references indexed in Scilit:
- Self-consumption: the interplay of autophagy and apoptosisNature Reviews Molecular Cell Biology, 2014
- Crosstalk between apoptosis, necrosis and autophagyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Pathogenesis, Diagnosis, and Management of CholangiocarcinomaGastroenterology, 2013
- Inhibition of MTOR Disrupts Autophagic Flux in PodocytesJournal of the American Society of Nephrology, 2012
- Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinomaAutophagy, 2011
- The Beclin 1 network regulates autophagy and apoptosisCell Death & Differentiation, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature Cell Biology, 2011
- Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cellsCancer Letters, 2009
- Functional Anatomy of Normal Bile DuctsThe Anatomical Record, 2008
- Activity of benzimidazole carbamates against L1210 mouse leukaemia cells: Correlation with in vitro tubulin polymerization assayBiochemical Pharmacology, 1985